A study to Assess the Efficacy and Safety of Namilumab in subjects with lung inflammatory disease
A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Resolve-Lung A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-labelExtension to Assess the ...
A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis A Study to Assess the Safety, Tolerability, and Efficacy of Namilumabin Participants With Active Car ...
A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With an Open-label Cohort to Assess the Safety, Tolerability, and Efficacy of Namilumab in Subjects With Active Cardiac Sarcoidosis A Randomized, Double-blind, Placebo-controlled, Phase 2a Study With an Open-labelCohort to Assess th ...
A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis A Study to Assess the Efficacy and Safety of Namilumabin Participants With Chronic Pulmonary Sarcoid ...
A Randomized, Double-blind, Placebo-Controlled Phase 2 Study With Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects With Chronic Pulmonary Sarcoidosis A Randomized, Double-blind, Placebo-Controlled Phase 2 Study With Open-labelExtension to Assess the ...